To Severe Pain
📧 Sign up to get email alerts when something new happens for To Severe Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-31FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)
FDA approved Eywa Pharma Inc's supplemental application for hydrocodone bitartrate and acetaminophen (hydrocodone/acetaminophen) under ANDA …
-
FDA approval · 2024-10-31FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental ANDA for oxymorphone hydrochloride from KVK-Tech, Inc., authorizing its generic product to be marketed.
-
FDA approval · 2024-02-27FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Eywa Pharma Inc)
FDA approved Eywa Pharma Inc's supplemental application for Hydrocodone Bitartrate and Acetaminophen.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain [Phase 3]
This document announces the completion of a Phase 3 extension study evaluating the safety of Q8003 in patients with acute moderate to severe…